Post by account_disabled on Feb 27, 2024 7:53:17 GMT
Covid-19 affects people with cancer by Agencies April 21, 2020 12:28 Specialists from the Spanish Lung Cancer Group (GECP) have launched the 'SOLID' study, in which 1,000 people with this tumor will participate, to discover how Covid-19 infection affects cancer patients, especially those with lung cancer. , and if they really acquire future immunity against the disease. Thus, through its more than 170 hospitals and 500 associated specialists, the GECP will perform immunity tests on lung cancer patients using the 'enzyme-linked immunosorbent assay' ('ELISA') method. "This test is considered the most reliable for carrying out these determinations and its implementation in large populations will allow us to know whether or not the infection and the epidemiological conditions of the pandemic in our patients have passed," explained the president of the GECP and head of Oncology at the Puerta de Hierro Hospital in Madrid, Mariano Provencio.
These data will be crossed with information on demographic variables and the current state of the disease: age, sex, stage, smoking history, comorbidities, symptoms, previous treatments for the disease and current treatment, and specific data on symptoms or income they have suffered and who may be related to Covid-19. In this sense, the interest of researchers is to know if all patients with cancer and Covid-19 really have a worse prognosis, a greater probability of hospitalization or ICU admission. Also, there may be differences in the prognosis depending on the oncological treatment received. "We want Oman WhatsApp Number to answer all these questions because in the absence of information there are many doubts about the use of chemotherapy or immunotherapy in these patients, what advice to give and what precautions to have," added Provencio. And, as the GECP has argued, the information available to specialists about the impact of the coronavirus on cancer patients is "scarce and limited to a specific geographical area", which justifies the interest in a prospective collection of all the data.
Cases with Covid-19 infection, past or active, and cancer. «In addition, in the particular case of lung cancer, given its incidence (the second in men), it is one of the neoplasms that has the greatest number of patients undergoing treatment at the present time, which highlights the importance of generating knowledge regarding Covid-19," added the doctor. GECP researchers believe that the 'SOLID' study will also allow us to know the reinfection rate or duration of immunity against Covid-19 in the future. "We know very little about the titer of antibodies after infection, and we are not aware of any similar study published either in oncology patients or in the general population of this extent," Provencio concluded.